Corneal cells are capable of expressing isoforms of the nitric oxide synthase (NOS), suggesting that significant quantities of nitric oxide (NO) are produced physiologically in the cornea.
32,33 Because the cornea absorbs approximately 80% of the incident ultraviolet B (UVB) light,
31 there is a potential for generating significant amounts of free radicals and ROS. Nitric oxide is a mediator in many complex cellular processes in ocular tissues.
34 Increased levels of nitric oxide have cytotoxic effects that are mediated by peroxynitrite,
35 which can be localized by the accumulation of a specific marker, nitrotyrosine.
36,37 Recently, other studies reported that KC corneas have elevated levels of inducible nitric oxide synthase (iNOS) and accumulate nitrotyrosine when compared with normal corneas or corneas affected by other diseases.
8 The expression of iNOS is usually associated with the generation of high levels of nitric oxide,
38,39 which in turn can react with superoxide molecules to form peroxynitrite. In the cornea, endothelial NOS (eNOS) activity has been demonstrated in the epithelium and endothelium.
40 The NO/cGMP pathway may be important in preventing corneal edema and maintaining normal corneal thickness,
40 and nitric oxide has been shown to be involved in inflammation, angiogenesis, and the maintenance of corneal thickness.
33,34 These previous results agree with the results obtained herein;
Figure 2 shows a higher amount of total nitrites when compared with healthy corneas, and strongly supports the proposal that reactive nitrogen species (nitric oxide and peroxynitrite) might be involved in keratoconus etiopathology.